| - GRCh37:
- Chr9:37430511-37430512
- GRCh38:
- Chr9:37430514-37430515
| GRHPR | T202fs | Primary hyperoxaluria, type II | Likely pathogenic (Feb 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424928
- GRCh38:
- Chr9:37424931
| GRHPR | C57Y | Primary hyperoxaluria, type II | Likely pathogenic (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429766
- GRCh38:
- Chr9:37429769
| GRHPR | Q178fs | Primary hyperoxaluria, type II | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429731
- GRCh38:
- Chr9:37429734
| GRHPR | Q166* | Primary hyperoxaluria, type II | Likely pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426564-37426565
- GRCh38:
- Chr9:37426567-37426568
| GRHPR | L107fs | Primary hyperoxaluria, type II | Likely pathogenic (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426585-37426598
- GRCh38:
- Chr9:37426588-37426601
| GRHPR | E113fs | Primary hyperoxaluria, type II | Likely pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429734-37429735
- GRCh38:
- Chr9:37429737-37429738
| GRHPR | A167fs | Primary hyperoxaluria, type II | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429820
- GRCh38:
- Chr9:37429823
| GRHPR | Q196fs | Primary hyperoxaluria, type II | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426942
- GRCh38:
- Chr9:37426945
| GRHPR | | not provided, Primary hyperoxaluria, type II | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37426804
- GRCh38:
- Chr9:37426807
| GRHPR | | not provided, Primary hyperoxaluria, type II | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37422656
- GRCh38:
- Chr9:37422659
| GRHPR | | not provided, Primary hyperoxaluria, type II | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432136
- GRCh38:
- Chr9:37432139
| GRHPR | | not provided, Primary hyperoxaluria, type II | Likely pathogenic (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37430545
- GRCh38:
- Chr9:37430548
| GRHPR | | not provided | Benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426634
- GRCh38:
- Chr9:37426637
| GRHPR | | not provided | Benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37425938
- GRCh38:
- Chr9:37425941
| GRHPR | | Primary hyperoxaluria, type II, not provided, Nephrolithiasis/nephrocalcinosis
| Benign/Likely benign (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37424938
- GRCh38:
- Chr9:37424941
| GRHPR | | Nephrolithiasis/nephrocalcinosis, not provided, Primary hyperoxaluria, type II
| Likely benign (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37426628
- GRCh38:
- Chr9:37426631
| GRHPR | | not provided | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426637
- GRCh38:
- Chr9:37426640
| GRHPR | | Primary hyperoxaluria, type II, not provided | Likely benign (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432041
- GRCh38:
- Chr9:37432044
| GRHPR | | not provided | Likely benign (Jun 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426592
- GRCh38:
- Chr9:37426595
| GRHPR | | not provided, Primary hyperoxaluria, type II | Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432116
- GRCh38:
- Chr9:37432119
| GRHPR | | not provided | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432114
- GRCh38:
- Chr9:37432117
| GRHPR | L282F | not provided | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436666
- GRCh38:
- Chr9:37436669
| GRHPR | P292S | Primary hyperoxaluria, type II | Uncertain significance (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr9:37429813
- GRCh38:
- Chr9:37429816
| GRHPR | A193V | not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Jun 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37425956
- GRCh38:
- Chr9:37425959
| GRHPR | | not provided | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424866
- GRCh38:
- Chr9:37424869
| GRHPR | | not provided, Nephrolithiasis/nephrocalcinosis, Primary hyperoxaluria, type II
| Likely benign (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37422781
- GRCh38:
- Chr9:37422784
| GRHPR | T12A | not provided, Primary hyperoxaluria, type II | Conflicting interpretations of pathogenicity (Oct 9, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr9:37422761
- GRCh38:
- Chr9:37422764
| GRHPR | R5Q | Primary hyperoxaluria, type II | Uncertain significance (Sep 4, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr9:37428533
- GRCh38:
- Chr9:37428536
| GRHPR | Q153* | Primary hyperoxaluria, type II | Likely pathogenic (Sep 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426553
- GRCh38:
- Chr9:37426556
| GRHPR | Y102* | Primary hyperoxaluria, type II | Likely pathogenic (Sep 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424894
- GRCh38:
- Chr9:37424897
| GRHPR | E46* | Primary hyperoxaluria, type II | Likely pathogenic (Dec 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429746
- GRCh38:
- Chr9:37429749
| GRHPR | R171C | not provided, Primary hyperoxaluria, type II | Uncertain significance (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432012
- GRCh38:
- Chr9:37432015
| GRHPR | V248I | not provided, Primary hyperoxaluria, type II | Uncertain significance (Dec 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37426638
- GRCh38:
- Chr9:37426641
| GRHPR | E131K | not provided | Conflicting interpretations of pathogenicity (Oct 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37425906-37425912
- GRCh38:
- Chr9:37425909-37425915
| GRHPR | | not provided | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37429778
- GRCh38:
- Chr9:37429781
| GRHPR | | not provided, Primary hyperoxaluria, type II | Conflicting interpretations of pathogenicity (Sep 27, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37428563
- GRCh38:
- Chr9:37428566
| GRHPR | R163C | Primary hyperoxaluria, type II | Uncertain significance (Jul 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37426621
- GRCh38:
- Chr9:37426624
| GRHPR | R125Q | not provided, Primary hyperoxaluria, type II | Uncertain significance (Jun 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37436911
- GRCh38:
- Chr9:37436914
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426543
- GRCh38:
- Chr9:37426546
| GRHPR | R99Q | Inborn genetic diseases, Primary hyperoxaluria, type II, not provided
| Uncertain significance (Dec 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37425969
- GRCh38:
- Chr9:37425972
| GRHPR | A89P | Primary hyperoxaluria, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424914
- GRCh38:
- Chr9:37424917
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432029
- GRCh38:
- Chr9:37432032
| GRHPR | D253E | Primary hyperoxaluria, type II | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37430610
- GRCh38:
- Chr9:37430613
| GRHPR | M234T | Primary hyperoxaluria, type II, not provided | Uncertain significance (Feb 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37430599
- GRCh38:
- Chr9:37430602
| GRHPR | F230L | Primary hyperoxaluria, type II, Nephrolithiasis/nephrocalcinosis, not provided
| Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37424907
- GRCh38:
- Chr9:37424910
| GRHPR | A50V | Primary hyperoxaluria, type II, Nephrolithiasis/nephrocalcinosis, not provided
| Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37424844
- GRCh38:
- Chr9:37424847
| GRHPR | C29Y | Primary hyperoxaluria, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429789
- GRCh38:
- Chr9:37429792
| GRHPR | R185H | Primary hyperoxaluria, type II | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429786
- GRCh38:
- Chr9:37429789
| GRHPR | G184E | Primary hyperoxaluria, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436664
- GRCh38:
- Chr9:37436667
| GRHPR | L291P | Primary hyperoxaluria, type II | Uncertain significance (Jul 4, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr9:37426631
- GRCh38:
- Chr9:37426634
| GRHPR | | not provided | Likely benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424838
- GRCh38:
- Chr9:37424841
| GRHPR | | not provided | Likely benign (Oct 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426589
- GRCh38:
- Chr9:37426592
| GRHPR | | Nephrolithiasis/nephrocalcinosis, not provided, Primary hyperoxaluria, type II
| Likely benign (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37429744
- GRCh38:
- Chr9:37429747
| GRHPR | R170Q | not provided, Primary hyperoxaluria, type II | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432026
- GRCh38:
- Chr9:37432029
| GRHPR | | not provided | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37425959
- GRCh38:
- Chr9:37425962
| GRHPR | | not provided, Primary hyperoxaluria, type II | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37430575
- GRCh38:
- Chr9:37430578
| GRHPR | | not provided, Primary hyperoxaluria, type II | Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37432032
- GRCh38:
- Chr9:37432035
| GRHPR | | not provided | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37430575
- GRCh38:
- Chr9:37430578
| GRHPR | | not provided, Nephrolithiasis/nephrocalcinosis, Primary hyperoxaluria, type II
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37426604
- GRCh38:
- Chr9:37426607
| GRHPR | | not provided, Primary hyperoxaluria, type II | Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37430644
- GRCh38:
- Chr9:37430647
| GRHPR | | Primary hyperoxaluria, type II, not provided | Likely pathogenic (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37429826-37429827
- GRCh38:
- Chr9:37429829-37429830
| GRHPR | E198fs | not provided, Primary hyperoxaluria, type II | Pathogenic (Aug 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37424897
- GRCh38:
- Chr9:37424900
| GRHPR | R47* | Primary hyperoxaluria, type II, not provided | Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37430524-37430578
- GRCh38:
- Chr9:37430527-37430581
| GRHPR | A206fs | not provided | Pathogenic (Feb 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432136-37432137
- GRCh38:
- Chr9:37432139-37432140
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Jun 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429833
- GRCh38:
- Chr9:37429836
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Apr 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436657-37436658
- GRCh38:
- Chr9:37436660-37436661
| GRHPR | L291fs | Primary hyperoxaluria, type II | Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436750
- GRCh38:
- Chr9:37436753
| GRHPR | E320* | Primary hyperoxaluria, type II, not provided | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37432003
- GRCh38:
- Chr9:37432006
| GRHPR | | not provided, Primary hyperoxaluria, type II | Likely pathogenic (Dec 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37422748
- GRCh38:
- Chr9:37422751
| GRHPR | M1L | Primary hyperoxaluria, type II | Likely pathogenic (Mar 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432133
- GRCh38:
- Chr9:37432136
| GRHPR | C288fs | Primary hyperoxaluria, type II | Likely pathogenic (Mar 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426646-37426648
- GRCh38:
- Chr9:37426649-37426651
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Feb 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37422881
- GRCh38:
- Chr9:37422884
| GRHPR | | Primary hyperoxaluria, type II | Likely benign (Dec 21, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37425989-37425991
- GRCh38:
- Chr9:37425992-37425994
| GRHPR | | not specified, Primary hyperoxaluria, type II | Uncertain significance (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37422881-37422882
- GRCh38:
- Chr9:37422884-37422885
| GRHPR | | Primary hyperoxaluria, type II | Likely benign (Dec 9, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37430507
- GRCh38:
- Chr9:37430510
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Nov 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37428480
- GRCh38:
- Chr9:37428483
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Oct 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37422748
- GRCh38:
- Chr9:37422751
| GRHPR | M1V | Primary hyperoxaluria, type II | Pathogenic/Likely pathogenic (Jul 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37436725-37436726
- GRCh38:
- Chr9:37436728-37436729
| GRHPR | N312fs | Primary hyperoxaluria, type II | Uncertain significance (Sep 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432118-37432119
- GRCh38:
- Chr9:37432121-37432122
| GRHPR | T284fs | Primary hyperoxaluria, type II | Likely pathogenic (Sep 5, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37428529-37428537
- GRCh38:
- Chr9:37428532-37428540
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Aug 25, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436656
- GRCh38:
- Chr9:37436659
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Jul 31, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424973
- GRCh38:
- Chr9:37424976
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (May 31, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436743-37436744
- GRCh38:
- Chr9:37436746-37436747
| GRHPR | E320fs | not provided, Primary hyperoxaluria, type II | Conflicting interpretations of pathogenicity (Mar 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37422749
- GRCh38:
- Chr9:37422752
| GRHPR | M1R | Primary hyperoxaluria, type II | Likely pathogenic (Apr 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436778
- GRCh38:
- Chr9:37436781
| GRHPR | | Primary hyperoxaluria, type II | Uncertain significance (Apr 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424973
- GRCh38:
- Chr9:37424976
| GRHPR | | not provided, Primary hyperoxaluria, type II | Likely pathogenic (Jun 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37432051-37432052
- GRCh38:
- Chr9:37432054-37432055
| GRHPR | G261fs | Primary hyperoxaluria, type II, not provided | Pathogenic/Likely pathogenic (Nov 1, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37425917-37425918
- GRCh38:
- Chr9:37425920-37425921
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Mar 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37432052-37432053
- GRCh38:
- Chr9:37432055-37432056
| GRHPR | K262* | Primary hyperoxaluria, type II | Likely pathogenic (Mar 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436681
- GRCh38:
- Chr9:37436684
| GRHPR | A297T | Primary hyperoxaluria, type II | Uncertain significance (Mar 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429730
- GRCh38:
- Chr9:37429733
| GRHPR | Q166fs | Primary hyperoxaluria, type II | Likely pathogenic (Jan 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37436756-37436757
- GRCh38:
- Chr9:37436759-37436760
| GRHPR | M322fs | Primary hyperoxaluria, type II | Uncertain significance (Dec 15, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37424945-37424946
- GRCh38:
- Chr9:37424948-37424949
| GRHPR | V63fs | Primary hyperoxaluria, type II | Likely pathogenic (Jan 5, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37429834
- GRCh38:
- Chr9:37429837
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Dec 28, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:37426656
- GRCh38:
- Chr9:37426659
| GRHPR | | Primary hyperoxaluria, type II, not provided | Likely pathogenic (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37436747
- GRCh38:
- Chr9:37436750
| GRHPR | G319W | Primary hyperoxaluria, type II, not provided | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:37424974
- GRCh38:
- Chr9:37424977
| GRHPR | | Primary hyperoxaluria, type II | Likely pathogenic (Jul 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37426584
- GRCh38:
- Chr9:37426587
| GRHPR | E113* | not provided, Primary hyperoxaluria, type II | Pathogenic/Likely pathogenic (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:37428511-37428512
- GRCh38:
- Chr9:37428514-37428515
| GRHPR | W145fs | Primary hyperoxaluria, type II | Likely pathogenic (Oct 10, 2016) | criteria provided, single submitter |